AMRN - Amarin Corporation plc
| Previous Close | 3.27 |
| Open | 3.27 |
| Bid | 3.22 x 900 |
| Ask | 3.23 x 3200 |
| Day's Range | 3.21 - 3.30 |
| 52 Week Range | 2.66 - 4.60 |
| Volume | 384,356 |
| Avg. Volume | 2,044,474 |
| Market Cap | 945.34M |
| Beta | 1.14 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.25 |
| Earnings Date | May 4, 2017 - May 8, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.60 |
- Zacks•3 hours ago
Is the Options Market Predicting a Spike in Amarin (AMRN) Stock?
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.
- Thomson Reuters StreetEvents•12 days ago
Edited Transcript of AMRN earnings conference call or presentation 2-May-18 11:30am GMT
Q1 2018 Amarin Corporation PLC Earnings Call
- Associated Press•19 days ago
Amarin: 1Q Earnings Snapshot
The Dublin-based company said it had a loss of 8 cents per share. Losses, adjusted for stock option expense, were 7 cents per share. The results met Wall Street expectations. The average estimate of three ...
- GlobeNewswire•19 days ago
Amarin Reports First Quarter 2018 Financial Results and Provides Update on Operations
REDUCE-IT Study On-Track for Reporting Top-Line Results by the End of Q3 2018. Management to Host Conference Call at 7:30 a.m. ET Today. BEDMINSTER, N.J. and DUBLIN, Ireland, May 02, 2018-- Amarin Corporation ...
- Motley Fool•20 days ago
3 Stocks That Could Put Tesla's Returns to Shame
Tesla has made investors a lot of money in recent years. Here are three new stocks we think could do the same for investors going forward.
- GlobeNewswire•25 days ago
Amarin To Report First Quarter 2018 Results and Host Conference Call On May 2, 2018
BEDMINSTER, N.J. and DUBLIN, Ireland, April 26, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- Zacks•27 days ago
Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.
- GlobeNewswire•28 days ago
Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer
BEDMINSTER, N.J., and DUBLIN, Ireland, April 23, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- GlobeNewswire•last month
New Research: Key Drivers of Growth for Amarin, Korea Electric Power, Star Bulk Carriers, 1-800 FLOWERS.COM, Clementia Pharmaceuticals, and Bank of Nova Scotia — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, April 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- GlobeNewswire•last month
Amarin Sponsors Three Scientific Presentations Scheduled for National Lipid Association Scientific Sessions
BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- Zacks•last month
Moving Average Crossover Alert: Amarin (AMRN)
Amarin Corporation plc (AMRN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
- GlobeNewswire•last month
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin-Treated Patients with Reduced Kidney Function and Persistent High Triglycerides
BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- ACCESSWIRE•last month
Wired News – Amarin’s REDUCE-IT Study Reached 100% Mark for Estimated Onset of Targeted Primary MACE
Stock Monitor: Pernix Therapeutics Holdings Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 6, 2018 / Active-Investors.com has just released a free research report on Amarin Corp. PLC (NASDAQ: ...
- Motley Fool•2 months ago
Boom-or-Bust News Is On Tap Soon for Amarin
Amarin has needle-moving news that's fast-approaching.
- GlobeNewswire•2 months ago
Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa® Promotion Initiatives
BEDMINSTER, N.J. and DUBLIN, Ireland, April 04, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- GlobeNewswire•2 months ago
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events
BEDMINSTER, N.J., and DUBLIN, Ireland, April 04, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- Zacks•2 months ago
Implied Volatility Surging for Amarin (AMRN) Stock Options
Surging implied volatility makes Amarin (AMRN) stock lucrative to the option traders.
- Investopedia•2 months ago
7 Stocks for the Biotech Takeover Wave
Biotech M&A activity took a bit of a breather in 2017, but expect a new wave of deals in 2018.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of AMRN earnings conference call or presentation 27-Feb-18 12:30pm GMT
Q4 2017 Amarin Corporation PLC Earnings Call
- GlobeNewswire•2 months ago
Amarin Sponsors Two Scientific Presentations Scheduled for National Kidney Foundation 2018 Spring Clinical Meetings
BEDMINSTER, N.J. and DUBLIN, Ireland, March 29, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- GlobeNewswire•2 months ago
Amarin to Present at the H.C. Wainwright Annual Global Life Sciences Conference
BEDMINSTER, N.J. and DUBLIN, Ireland, March 28, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- GlobeNewswire•2 months ago
Amarin Commemorates National Triglycerides Day on March 28
BEDMINSTER, N.J. and DUBLIN, Ireland, March 27, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- GlobeNewswire•2 months ago
Amarin Announces First Middle East Approval for Vascepa®
BEDMINSTER, N.J. and DUBLIN, Ireland, March 21, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
- Motley Fool•2 months ago
3 Stocks That Could Put Alibaba's Returns to Shame
Alibaba may make the headlines, but here are three other stocks that are equally strong investment opportunities.
- GlobeNewswire•2 months ago
New Research Coverage Highlights Amarin, Corbus Pharmaceuticals, Green Brick Partners, Immutep, Texas Capital Bancshares, and G1 THERAPEUTICS — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, March 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
